Delivery Order SPE2DP20D0002-SPE2DP25F2790
Award Date
1/28/25
Potential Completion Date
2/4/25
Potential Value
$330K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $476,414.19 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines, which support military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies, including the Department of Veterans...
This federal contract award, valued at $158,804.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a large, foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 27, 2024. Teva Pharmaceuticals USA, Inc. has a long history of supplying...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $158,804.73, is for the delivery of Adenovirus Type 4 vaccine, a critical product that supports military immunization programs. The contract has a period of performance through July 30, 2024 and is a firm-fixed-price type. Teva Pharmaceuticals USA, Inc. has received multiple delivery orders...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a large, foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract has a total ceiling value of $1,156,098.51 and a period of performance ending on February 4, 2025. Teva Pharmaceuticals USA, Inc. is an experienced federal...
This federal contract award, valued at $5,285,021.76, was issued by the Defense Logistics Agency (DLA) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is a firm-fixed-price delivery order for the supply of Adenovirus Type 4 vaccine, which supports military immunization programs. The award has an ultimate completion date of February 4, 2025. Teva Pharmaceuticals USA, Inc. is a major supplier of critical pharmaceutical products to various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $635,218.92, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract is a firm-fixed-price delivery order with a period of performance through November 19, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $158,804.73, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract has a final completion date of September 24, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $635,218.92, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. This award is not a set-aside and Teva, as a large business, competed without any small business designations. Teva is a major supplier of critical...
This is a delivery order awarded by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $476,414.19 firm-fixed-price contract is for the supply of Adenovirus Type 4 vaccine, which is used in military immunization programs. The contract has an ultimate completion date of April 30, 2024. Teva Pharmaceuticals USA, Inc. is an experienced federal contractor, holding several indefinite-delivery...
This is a firm fixed-price delivery order awarded to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) Troop Support Medical. The $158,804.73 contract is for the supply of Adenovirus Type 4 vaccines, with a performance period running through June 25, 2024. Teva Pharmaceuticals USA, Inc. is not designated under any set-aside program for this award. This delivery order is part of Teva's broader role as a prime...